Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

M.D. Anderson Researcher Pazdur Will Head FDA Oncologics Division

Executive Summary

FDA's Division of Oncologic Drug Products will be led by M.D. Anderson Educational Programs Director Richard Pazdur, MD, starting Sept. 26.

You may also be interested in...



FDA GI Division Director Justice Is Returning To FDA From Genentech

Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September

FDA GI Division Director Justice Is Returning To FDA From Genentech

Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September

FDA “Unmet Medical Need” Definition Can Be Moving Target – ImClone CEO

Biotech product development would be helped by more flexibility from FDA in applying the standard of an "unmet medical need," ImClone CEO Harlan Waksal suggested during a June 3 Manhattan Institute Capitol Hill briefing on the future of medical progress

Related Content

UsernamePublicRestriction

Register

PS034473

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel